Taking advantage of the optical transparency of our zebrafish neuroblastoma model, which allows us to monitor fluorescent tumor cell progression in vivo, we further investigated the compound effects of loss of nf1 and gain of MYCN on the kinetics of neuroblastoma progression. The gene discussed is NF1; the disease is neoplasm.